Parameters | Low De Ritis ratio (< 1.3, N = 49) | High De Ritis ratio (≥1.3, N = 69) | P |
---|---|---|---|
Pathologic stage | Â | Â | 0.75 |
 T0, Tis, Ta | 4 (8.2) | 6 (8.7) |  |
 T1 | 11 (22.4) | 17 (24.6) |  |
 T2 | 16 (32.7) | 15 (21.7) |  |
 T3 | 12 (24.5) | 22 (31.9) |  |
 T4 | 6 (12.2) | 9 (13.0) |  |
Histologic grade | Â | Â | 0.072 |
 Low | 4 (8.2) | 1 (1.4) |  |
 High | 45 (91.8) | 68 (98.6) |  |
Lymph node involvement | Â | 0.777 | |
 No | 38 (77.6) | 55 (79.7) |  |
 Yes | 11 (22.4) | 14 (20.3) |  |
Lymphovascular invasion | Â | 0.465 | |
 No | 41 (83.7) | 54 (78.3) |  |
 Yes | 8 (16.3) | 15 (21.7) |  |
Median follow-up periods (months, range) | 40 (6.5–83.3) | 31.8 (4.3–95.3) | 0.089 |
Metastasis | Â | Â | 0.015 |
 No | 37 (75.5) | 37 (53.6) |  |
 Yes | 12 (24.5) | 32 (46.4) |  |
Cancer-related death | Â | Â | 0.045 |
 No | 39 (79.6) | 43 (62.3) |  |
 Yes | 10 (20.4) | 26 (37.7) |  |
Overall death | Â | Â | 0.039 |
 No | 38 (77.6) | 41 (59.4) |  |
 Yes | 11 (22.4) | 28 (40.6) |  |